Recoflavone clinical trials
Also written DA-6034.
How each study uses recoflavone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- DA-6034
- 2
Studies by the year they started
3 studies that test it; most in 2008 (1)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Dong-A ST Co., Ltd. (2) · Dong-A Pharmaceutical Co., Ltd. (1)
Studies
Open first, then newest update. How each study uses recoflavone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Phase II Study of DA-6034 Eye Drops in Dry Eye SyndromeCompletedPhase 2Dong-A ST Co., Ltd.NCT01670357Written as DA-6034 3%How we know
- Phase I Study to Evaluate the Tolerability of Eye Drop DA-6034 in Healthy VolunteersCompletedPhase 1Dong-A ST Co., Ltd.NCT01162954Written as DA-6034How we know
- A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034Status unknownPhase 3Dong-A Pharmaceutical Co., Ltd.NCT01813812Written as DA-6034How we know
Codes
What other systems call recoflavone · ClinicalTrials.gg INT004183
- MeSH (NLM) C121889recoflavoneOne source NLM
- UNII (FDA) U96J5LG435RECOFLAVONEConfirmed FDA, NLM, Wikidata
- Wikidata Q27290945recoflavoneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152170RecoflavoneOne source FDA
- DrugBank DB12058One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C121889 | recoflavone | One source NLM |
| UNII (FDA) | U96J5LG435 | RECOFLAVONE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27290945 | recoflavone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152170 | Recoflavone | One source FDA |
| DrugBank | DB12058 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.